Rapid manipulation of the porcine epidemic diarrhea virus genome by CRISPR/Cas9 technology

被引:29
|
作者
Peng, Qi [1 ,2 ]
Fang, Liurong [1 ,2 ]
Ding, Zhen [1 ,2 ,3 ]
Wang, Dang [1 ,2 ]
Peng, Guiqing [1 ,2 ]
Xiao, Shaobo [1 ,2 ]
机构
[1] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China
[2] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan 430070, Peoples R China
[3] Jiangxi Agr Univ, Coll Anim Sci & Technol, Jiangxi Prov Key Lab Anim Sci & Technol, Nanchang 330045, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Porcine epidemic diarrhea virus; Reverse genetics system; CRISPR/Cas9; PROTEIN; CORONAVIRUSES;
D O I
10.1016/j.jviromet.2019.113772
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Porcine epidemic diarrhea virus (PEDV) is a highly pathogenic enteric coronavirus causing lethal watery diarrhea in suckling piglets. Reverse genetics is a valuable tool to study the functions of viral genes and to generate vaccine candidates. In this study, a full-length infectious cDNA clone of the highly virulent PEDV strain AJ1102 was assembled in a bacterial artificial chromosome (BAC). The rescued virus (rAJ1102) exhibited similar proliferation characteristics in vitro to the wildtype AJ1102. Using CRISPR/Cas9 technology, a recombinant virus rAJ1102-Delta ORF3-EGFP in which the ORF3 gene was replaced with an EGFP gene, was successfully generated, and its proliferation characteristics were compared with the parental rAJ1102. Importantly, it just took one week to construct the recombinant PEDV rAJ1102-Delta ORF3-EGFP using this method, providing a more efficient platform for PEDV genome manipulation, which could also be applied to other RNA viruses.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Ethical aspects of the Crispr/Cas9 technology
    Bout, Henriette
    TRANSGENIC RESEARCH, 2016, 25 (02) : 210 - 211
  • [42] CRISPR/Cas9 Tumor Targeting Technology
    Li, Xiaoxue
    Hu, Zixi
    Huang, Yingying
    Li, Jieping
    Yang, Wei
    Huang, Xianing
    Duan, Siliang
    Huang, Yong
    Lu, Xiaoling
    Zhao, Yongxiang
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2016, 16 (12) : 12086 - 12098
  • [43] Recent Progress in CRISPR/Cas9 Technology
    Mei, Yue
    Wang, Yan
    Chen, Huiqian
    Sun, Zhong Sheng
    Ju, Xing-Da
    JOURNAL OF GENETICS AND GENOMICS, 2016, 43 (02) : 63 - 75
  • [44] Legal Regulation of Plant Genome Editing with the CRISPR/Cas9 Technology as an Example
    Medvedieva, M. O.
    Blume, Ya. B.
    CYTOLOGY AND GENETICS, 2018, 52 (03) : 204 - 212
  • [45] Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
    Gaetan Burgio
    Genome Biology, 19
  • [46] Legal Regulation of Plant Genome Editing with the CRISPR/Cas9 Technology as an Example
    M. O. Medvedieva
    Ya. B. Blume
    Cytology and Genetics, 2018, 52 : 204 - 212
  • [47] Recent Progress in CRISPR/Cas9 Technology
    Yue Mei
    Yan Wang
    Huiqian Chen
    Zhong Sheng Sun
    Xing-Da Ju
    Journal of Genetics and Genomics, 2016, 43 (02) : 63 - 75
  • [48] State-of-the-art CRISPR/Cas9 Technology for Genome Editing in Trypanosomatids
    Lander, Noelia
    Chiurillo, Miguel A.
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 2019, 66 (06) : 981 - 991
  • [49] Recent Advances in Chemical Control of CRISPR/Cas9 Genome Editing Technology
    Xiao, Heng
    Li, Yongkui
    Xing, Xiwen
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2023, 44 (03):
  • [50] The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses
    Gilani, Usman
    Shaukat, Memoona
    Rasheed, Arisha
    Shahid, Mehak
    Tasneem, Fareeda
    Arshad, Muhammad
    Rashid, Naeem
    Shahzad, Naveed
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (01) : 1 - 13